Patent ID: 6911454

Claim:
A method for treating and thereby reducing drug resistant uterine, ovarian, breast, lymphoma, cartilage/bone, leukemia, liver, abdominal area, lung, cervical, pelvic, adrenal gland, iliac, Hodgkin's disease and thyroid cancers in a patient comprising: administering to the patient in vivo effective concentration of (1) a compound having the following formula: where R 1 and R 1 ′ are the same or different short chained carbon based moieties; R 2 is CH 3 or C 2 H 5 and R 3 is CH 3 or Hydrogen, and the isomeric configuration at the C-1′ chiral carbon location is “S”, and (2) at least one principal drug known to be effective for treating whichever of said cancers is being treated, administered sufficiently contemporaneously with said compound that said cancer is exposed to said compound and said principal drug simultaneously.